Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.
Scholars argue that increased use of direct-to-consumer genetic testing creates hidden privacy risks.
Court’s ruling could determine the procedure for changing hospital reimbursement formulas.
Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.
States should shift incentives to reduce nonmedical exemptions while respecting the choice not to vaccinate.
HIPAA does not stop health care providers from disclosing patient information to provide better care.
The Right to Try Act represents an important step toward helping dying patients with little recourse.
Experts say federal agencies must clarify rules permitting payment to research subjects.
Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.
Public officials and sober living home operators dispute whether sober living homes need more oversight.
Scholar argues that FDA should reform its regulation of algorithm-based medicine.